tirzepatide obstructive sleep apnea fda approval 2024 approves first medication for — which also promotes weight loss Dr Alo, DO, FACC on

Patients generally seem happy with their GLP-1 injections

Retatrutide Therapy A triple-action investigational peptide designed to interact with GLP-1, GIP, and glucagon receptors Your provider will review benefits, risks, and eligibility before recommending any treatment

Akimoto, H

Importance of Patient Education Educating patients about the potential side effects of semaglutide, including heartburn, and the availability of alternative treatments is crucial

Potential Limitations and Cautions While AOD 9604s prospects seem promising, its pivotal to acknowledge potential limitations: Data on long-term safety is still in the nascent stages

Heres an overview of the most popular GLP-1 medications and their key features: Semaglutide (Brand names: Ozempic, Wegovy, Rybelsus Features: Once-weekly injection (Ozempic, Wegovy) or daily oral tablet (Rybelsus) Approved for type 2 diabetes (Ozempic, Rybelsus) and weight management (Wegovy) Benefits: Significant weight loss Improved glycemic control Cardiovascular benefits Liraglutide (Brand names: Victoza, Saxenda) Features: Daily injection Victoza approved for type 2 diabetes, Saxenda for weight management Benefits: Moderate weight loss Improved blood sugar control Cardiovascular benefits Dulaglutide (Brand name: Trulicity) Features: Once-weekly injection Approved for type 2 diabetes Benefits: Improved glycemic control Moderate weight loss Cardiovascular benefits Tirzepatide (Brand name: Mounjaro) Features: Once-weekly injection Approved for type 2 diabetes, under review for weight management Dual GIP and GLP-1 receptor agonist Benefits: Significant weight loss Improved glycemic control Potential cardiovascular benefits Key differences: Efficacy: Semaglutide and tirzepatide generally show the most significant weight loss and glycemic control improvements